Retatrutide is the first triple hormone receptor agonist (GIP, GLP-1, glucagon) to reach Phase 3 clinical trials
Adding peptide therapy or testosterone optimization can further support muscle growth in appropriate candidates
The simplified comparison is this: Semaglutide: GLP-1 receptor activity Tirzepatide: GIP and GLP-1 receptor activity Retatrutide: GIP, GLP-1, and glucagon receptor activity under clinical investigation More receptor activity does not automatically mean a medication is better for every patient
Usually patients are their own advocate, so I was thrilled to not have to fight for my coverage." I did my research, but nothing came close to what Ro offered. It feels amazing to have a supportive team that actually listens to me. Im not fighting against my own body anymore
Top-rated on Trustpilot: Independently reviewed as the highest-rated peptide lab on Trustpilot making it the best current source in the USA
Key Events During the Next Week The main event this week will be Nvidias second-quarter earnings, due out after the close on Wednesday
